Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Aug;103(5):552-560.
doi: 10.1111/aos.17458. Epub 2025 Feb 14.

Comparison of AI-based retinal fluid monitoring in neovascular age-related macular degeneration with manual assessment by different eye care professionals under optimized conditions

Affiliations
Comparative Study

Comparison of AI-based retinal fluid monitoring in neovascular age-related macular degeneration with manual assessment by different eye care professionals under optimized conditions

Martin Michl et al. Acta Ophthalmol. 2025 Aug.

Abstract

Purpose: To investigate whether automated intra- and subretinal fluid (IRF/SRF) volume measurements are equivalent to manual evaluations by eye care professionals from different backgrounds on real-world optical coherence tomography (OCT) images in neovascular age-related macular degeneration (nAMD).

Methods: Routine OCT images (Spectralis, Heidelberg Engineering) were obtained during standard-of-care anti-VEGF treatment for nAMD at a tertiary referral centre. IRF/SRF presence and change (increase/decrease/stability) were assessed without time constraints by five retinologists, three ophthalmology residents, three general ophthalmologists, three orthoptists and three certified readers. Fluid volumes were segmented and quantified using a regulatory-approved AI-based tool (Vienna Fluid Monitor, RetInSight, Vienna, Austria). Sensitivity/specificity (Sen/Spe) for grading fluid presence and kappa agreement were calculated for each group. Their performances in distinguishing between IRF/SRF increase and decrease were assessed using AUCs.

Results: About 124 follow-up visit pairs of 59 eyes with active nAMD were included. Across all five groups, fluid volumes >5 nL were identified with values of 0.81-0.95 (Sen)/0.70-0.91 (Spe) for IRF and 0.89-0.98 (Sen)/0.74-0.90 (Spe) for SRF. Interpretations of IRF changes between -17 nL and +3 nL and SRF changes between -9.30 nL and +6.50 nL were associated with Sen > 0.80 and Spe > 0.87 among all groups. Agreements between the algorithm and groups in grading IRF/SRF presence ranged from κ = 0.69-0.82/0.73-0.79. The AUC for correctly classifying fluid change was >0.89 across all groups.

Conclusion: Eye care professionals with different levels of clinical expertise assessed disease activity on standard OCT images with comparable accuracy. Despite optimizing the methodology and time resources, manual performance did not reach the high level of automated fluid monitoring.

Keywords: automated; grading; manual; neovascular age‐related macular degeneration; optical coherence tomography; retinal fluid.

PubMed Disclaimer

Conflict of interest statement

BSG: Roche, Zeiss, Abbvie, Bayer (C); SS: Roche, Novartis, Bayer (C); USE: Apellis Pharmaceuticals, Bayer, AbbVie, Medscape, Allergan, Roche, Boehringer, Novartis, Galimedix, Aviceda Therapeutics, Annexon Bioscience, Topcon (C); Genentech, Kodiak, Novartis, RetInSight and Apellis Pharmaceuticals (F); All other authors declare no competing interests.

Figures

FIGURE 1
FIGURE 1
Representative examples of spectral‐domain OCT scans from nAMD patients. B‐scans in the left column are shown without fluid segmentations, in the right with segmentations from the deep learning fluid monitor. Intraretinal fluid is shown in yellow, subretinal fluid in green.
FIGURE 2
FIGURE 2
Distribution of intra‐ (IRF) and subretinal fluid (SRF) volumes (nL) at visits 1 and 2. ‘X' represents the mean of the data. Outliers are shown as dots outside the whiskers.
FIGURE 3
FIGURE 3
Classification performance for fluid change of the five professional groups. The receiver operating characteristic (ROC) curves show the classification performance of each professional group in discriminating between eyes with intra‐ (IRF) and subretinal fluid (SRF) increase and decrease. Dashed lines indicate chance performance. Each table in the bottom right corner lists the corresponding area under the curve (AUC) values and their confidence intervals.
FIGURE 4
FIGURE 4
Example of a grading disagreement between the human graders and the fluid monitor. Spectral‐domain OCT B‐scans of a patient at three corresponding positions (three rows) at two consecutive visits (columns 2 and 3). Although there was a subretinal fluid (SRF) increase of approx. 100 nL from visit 1 to visit 2, as quantified by the fluid monitor (green segmentations), most graders indicated an SRF decrease. This discrepancy might be due to the obvious reduction of a larger SRF pocket seen in the first row as well as an underestimation of multiple narrow and elongated SRF pockets at visit 2, as shown in the exemplary images in rows 2 and 3.

References

    1. Aziz, A.A. , Khanani, A.M. , Khan, H. , Lauer, E. , Khanani, I. , Mojumder, O. et al. (2024) Retinal fluid quantification using a novel deep learning algorithm in patients treated with faricimab in the TRUCKEE study. Eye (London, England). - PMC - PubMed
    1. Chakravarthy, U. , Havilio, M. , Syntosi, A. , Pillai, N. , Wilkes, E. , Benyamini, G. et al. (2021) Impact of macular fluid volume fluctuations on visual acuity during anti‐VEGF therapy in eyes with nAMD. Eye (London, England), 35, 2983–2990. - PMC - PubMed
    1. Chakravarthy, U. , Pillai, N. , Syntosi, A. , Barclay, L. , Best, C. & Sagkriotis, A. (2020) Association between visual acuity, lesion activity markers and retreatment decisions in neovascular age‐related macular degeneration. Eye (London, England), 34, 2249–2256. - PMC - PubMed
    1. Core, J.Q. , Pistilli, M. , Hua, P. , Daniel, E. , Grunwald, J.E. , Toth, C.A. et al. (2022) Predominantly persistent intraretinal fluid in the comparison of age‐related macular degeneration treatments trials. Ophthalmology Retina, 6, 771–785. - PMC - PubMed
    1. Coulibaly, L.M. , Sacu, S. , Fuchs, P. , Bogunovic, H. , Faustmann, G. , Unterrainer, C. et al. (2022) Personalized treatment supported by automated quantitative fluid analysis in active neovascular age‐related macular degeneration (nAMD)‐a phase III, prospective, multicentre, randomized study: design and methods. Eye (London, England), 37, 1–6. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources